About
The ResMed SaaS RD team is looking for a Machine Learning Engineer to work on products that change the way technology is used to deliver healthcare. Do you want to build amazing products and tackle complex questionsAt ResMed SaaS, you ll have the opportunity to do just that. As a member of the ResMed SaaS ML AI Team, you ll be creating ways to provide better care for the aging population. See your work improve healthcare each day!
Updates & Highlights
simplywall.st · about 18 hours ago
Did Morgan Stanley’s GLP-1 Downgrade Just Shift ResMed's (RMD) Investment Narrative?
simplywall.st · 4 days ago
ResMed (RMD) Stock Could Be 30.3% Undervalued After Morgan Stanley Downgrade
Moomoo · 4 days ago
Morgan Stanley Downgrades ResMed(RMD.US) to Hold Rating, Cuts Target Price to $230
Recent Openings
View all 1 jobs arrow_forwardMachine Learning Engineer
location_on Bengaluru, India
All Jobs
Machine Learning Engineer
location_on Bengaluru, India
Culture & Mission
Benefits & Perks
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Resmed?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentDid Morgan Stanley’s GLP-1 Downgrade Just Shift ResMed's (RMD) Investment Narrative?
Did Morgan Stanley’s GLP-1 Downgrade Just Shift ResMed's (RMD) Investment Narrative?
simplywall.st · about 18 hours ago
ResMed (RMD) Stock Could Be 30.3% Undervalued After Morgan Stanley Downgrade
ResMed (RMD) Stock Could Be 30.3% Undervalued After Morgan Stanley Downgrade
simplywall.st · 4 days ago
Morgan Stanley Downgrades ResMed(RMD.US) to Hold Rating, Cuts Target Price to $230
Morgan Stanley Downgrades ResMed(RMD.US) to Hold Rating, Cuts Target Price to $230
Moomoo · 4 days ago
ResMed Inc. stock rises Thursday, outperforms market
ResMed Inc. stock rises Thursday, outperforms market
MarketWatch · 5 days ago
Stocks making big moves yesterday: Nubank, Ocular Therapeutix, Mondelez, ResMed, and Sonos
Stocks making big moves yesterday: Nubank, Ocular Therapeutix, Mondelez, ResMed, and Sonos
Yahoo Finance · 5 days ago
ResMed Is Near Its 52-Week Low Despite 21% EPS Growth: What the GLP-1 Fear Is Getting Wrong
ResMed Is Near Its 52-Week Low Despite 21% EPS Growth: What the GLP-1 Fear Is Getting Wrong
TIKR.com · 5 days ago
ResMed Loses Bull as Margin Outlook Moderates -- Market Talk
ResMed Loses Bull as Margin Outlook Moderates -- Market Talk
Moomoo · 5 days ago
ResMed Inc. stock falls Wednesday, underperforms market
ResMed Inc. stock falls Wednesday, underperforms market
MarketWatch · 6 days ago
Why ResMed (RMD) Shares Are Falling Today
Why ResMed (RMD) Shares Are Falling Today
Yahoo Finance · 6 days ago
Why ResMed (RMD) Shares Are Falling Today
Why ResMed (RMD) Shares Are Falling Today
TradingView · 6 days ago
Lobbying Update: $40,000 of RESMED CORP. lobbying was just disclosed
Lobbying Update: $40,000 of RESMED CORP. lobbying was just disclosed
Quiver Quantitative · 6 days ago
ResMed Inc. Stock 12‑Month Price Target Cut to $277.74, Implies 43% Upside
ResMed Inc. Stock 12‑Month Price Target Cut to $277.74, Implies 43% Upside
TradingView · 6 days ago
ResMed stock downgraded at Morgan Stanley (RMD:NYSE)
ResMed stock downgraded at Morgan Stanley (RMD:NYSE)
Seeking Alpha · 6 days ago
Resmed Completes Acquisition of Noctrix Health
Resmed Completes Acquisition of Noctrix Health
San Diego Business Journal · 6 days ago
Morgan Stanley downgrades ResMed stock rating on margin concerns
Morgan Stanley downgrades ResMed stock rating on margin concerns
Investing.com · 6 days ago
ResMed Inc. stock falls Monday, underperforms market
ResMed Inc. stock falls Monday, underperforms market
MarketWatch · 8 days ago
ResMed Inc. stock falls Monday, underperforms market
ResMed Inc. stock falls Monday, underperforms market
MarketWatch · 8 days ago
Citi Maintains ResMed(RMD.US) With Buy Rating, Cuts Target Price to $270
Citi Maintains ResMed(RMD.US) With Buy Rating, Cuts Target Price to $270
Moomoo · 8 days ago
Citigroup Adjusts Price Target on ResMed to $270 From $340, Maintains Buy Rating
Citigroup Adjusts Price Target on ResMed to $270 From $340, Maintains Buy Rating
marketscreener.com · 8 days ago
Will GLP-1 Pressure and Insider Selling Change ResMed's (RMD) Long-Term Sleep-Health Narrative
Will GLP-1 Pressure and Insider Selling Change ResMed's (RMD) Long-Term Sleep-Health Narrative
simplywall.st · 8 days ago